Advertisements


Ampio adds two study sites to expand clinical trial with Ampion for COVID-19

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 23rd, 2021

Ampio reports data from clinical trial of inhaled Ampion

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 1st, 2021

J&J"s single-dose coronavirus vaccine is 66% effective against COVID-19, raising worries that some variants may lower protection

J&J's shot was more effective among volunteers in the US than in Latin America and South Africa, where new strains are circulating. A clinical trial volunteer participates in Johnson & Johnson's study to test a coronavirus vaccin.....»»

Category: dealsSource: nytJan 29th, 2021

Novavax’s Covid-19 vaccine nearly 90% effective in U.K. study, much less in South Africa

Novavax Inc. said Thursday its Covid-19 vaccine candidate was found to be 89.3% effective based on interim data from its clinical trial in the United Kingdom — where a new variant of the virus originated. The results make Novavax’s candidate, called NV.....»»

Category: topSource: bizjournalsJan 28th, 2021

Ampio completes Phase 1 trial of Ampion in COVID-19, initiates Phase 2

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 17th, 2020

Gilead Sciences reports positive data in trial of remdesivir as treatment for COVID-19

Gilead Sciences Inc. said that its experimental COVID-19 therapy remdesivir met the main goal in a government-funded clinical trial and that a shorter dosing regimen was as successful as a longer one in a separate study......»»

Category: topSource: marketwatchApr 29th, 2020

Gilead"s stock halted, says remdesivir met primary endpoint in government study

Gilead Sciences Inc. said Wednesday morning that a government-run clinical trial evaluating its experimental drug remdesivir in certain COVID-19 patie.....»»

Category: topSource: marketwatchApr 29th, 2020

Novartis to conduct hydroxychloroquine trial for hospitalized COVID-19 patients

Novartis said it will proceed with a Phase III clinical trial of hydroxychloroquine in hospitalized patients with COVID-19 disease. The trial will be of approximately 440 patients at more than a dozen sites in the U.....»»

Category: topSource: marketwatchApr 20th, 2020

Incyte, Novartis launch drug study to treat coronavirus complication

Incyte Corp. said Friday it and Novartis AG started a late-stage clinical trial to study a drug meant to treat a serious complication of COVID-19. The biotech company said it was testin.....»»

Category: topSource: marketwatchApr 17th, 2020

NextCure says COVID-19 put "significant strain" on clinical trial sites

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 13th, 2020

Ampio suspends patient enrollment in Phase 3 clinical trial of Ampion

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 24th, 2020

Ampio announces progress in SPA Phase 3 clinical trial for Ampion

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 17th, 2019

FDA says Ampio to complete additional trial under SPA for Ampion study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 13th, 2018

RedHill Biopharma to expand opaganib global Phase 2/3 COVID-19 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 23rd, 2021

Novavax completes enrollment in Phase 3 clinical trial for its COVID-19 vaccine candidate

Shares of Novavax Inc. were down 6.2% in trading on Monday after the company said it had completed enrollment of the P.....»»

Category: topSource: marketwatchFeb 22nd, 2021

Immunic announces IMU-838 study shows clinical activity in COVID-19 patients

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 17th, 2021

Gilead, Galapagos drug fails in Phase 3 clinical study

Shares of Gilead Sciences Inc. were down 0.1% in premarket trading on Thursday, the day after the company said an experimental idiopathic pulmonary fibrosis drug it was developing with Galapagos failed a Phase 3 clinical trial. Shares o.....»»

Category: topSource: marketwatchFeb 11th, 2021

Ampio reports promising early data from COVID drug trial, Fox Denver says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 9th, 2021

Corvus begins Phase 3 clinical trial of CPI-006 for COVID-19 patients

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 4th, 2021

Publix adds Nassau County to list of Covid vaccination sites

Appointments can be made starting at 6 a.m. Wednesday for Publix locations in 23 Florida counties......»»

Category: topSource: bizjournalsFeb 2nd, 2021

J&J CEO: Expect Phase 3 results for its COVID-19 vaccine candidate early next week

Johnson & Johnson expects to share details from the Phase 3 clinical trial for its COVID-19 vaccine candidate "early next week,.....»»

Category: topSource: marketwatchJan 26th, 2021